Condition
Adenosine Triphosphate Activities
Total Trials
2
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Terazosine
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Early Phase 1 (1)
Trial Status
Recruiting2
Clinical Trials (2)
Showing 2 of 2 trials
NCT03685721Recruiting
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
NCT07224269Early Phase 1Recruiting
Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis
Showing all 2 trials
Research Network
Common Treatments
- Terazosine1
Active Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)1
- University of Iowa1
Top Investigators
University of Iowa
National Heart, Lung, and Blood Institute (NHLBI)
Related Conditions
- Amyotrophic Lateral Sclerosis1
- Sickle Cell1
- Pklr Variants1